Top 9 Techno-Funda Stock Picks for CY23 (30% upside). This is India’s decade, ride with conviction. CY23 will be strong year with Nifty target of 21400. Nifty poised to reach 50000 by CY30. Mid-Caps are in mid-cycle of multi year bull phase & will outperform
Posts in category RJ Fan Club
Indian Hotels is rapidly scaling up margin-accretive new business (20-12-2022)
Indian Hotels is rapidly scaling up margin-accretive new business. These business are high margin accretive with high growth runway thereby driving up the RoCE. New business is expected to contribute ~26% to operating profits by FY25. Buy for TP of Rs 390
Indian Hotels is rapidly scaling up margin-accretive new business
GAIL’s valuation is overly pessimistic & ignores its solid business model (20-12-2022)
GAIL's valuation of <7x FY24E EPS & just 5.3x EV/EBITDA is overly pessimistic & ignores its solid business model & strong long-term prospects. It is well below its 5-year valuation bands. BUY for TP of Rs127 (30% upside) which is also below peak valuation
GAIL's valuation is overly pessimistic & ignores its solid business model
JB Chemicals is the preferred pick in the Pharma sector: Nirmal Bang (19-12-2022)
JB Chem is the preferred pick in Pharma sector due to its aggressive growth focus in the domestic market, strong financials &healthy FCF. Its units are low risk with no USFDA inspections since 2019. No product recall or serious complaints in last 14 years
JB Chem is a steady performer going from strength to strength. The stock has given 600% gain in 5 years & 28% YoY. It is almost debt-free, has RoE of 18%. TTM P/E of 41x is lower than Sun Pharma (58) but higher than Cipla (35), Divis (30)…
JB Chemicals is the preferred pick in the Pharma sector: Nirmal Bang
PCBL is a carbon black giant set to grow at a fast clip (19-12-2022)
PCBL is a carbon black giant set to grow at a fast clip. It is a proxy play on tyre growth story. The stock is trading at inexpensive valuations. Buy due to increasing share of speciality business, robust volume growth & rising exports. TP Rs 183 (35% upside)
Latest Motilal Oswal Wealth Creation Study (11-12-2022)
The latest Motilal Oswal Wealth Creation Study points out that consistent companies, even from volatile sectors, have created enormous wealth of as much as 45% CAGR over 15 years while the Nifty gave only 9% CAGR. The precise methodology for identifying such companies & sectors is explained in detail
Buy Greepanel Industries for target price of Rs 595 (54% upside) (10-12-2022)
GREENP has a long runway before takeoff. It is trading at ~15x FY24E EPS which is attractive given its strong growth prospects, leadership position in MDF, improving balance sheet & return ratios. 34% discount to Century Ply. Buy for TP of 595 (54% gain)
Buy Axis Bank for target price of Rs 1195 (26-11-2022)
AXSB is on track to deliver steady performance of 14-15% RoE over the next couple of years. Enhanced productivity and gradual exercising of pricing power in chosen segments could drive sustained medium-term RoEs & same P/E multiple of ICICIB. Buy for TP of Rs 1195 (35% gain)
Defense stocks (26-11-2022)
Defense stocks have given formidable returns of upto 200% on a YoY basis. Experts say there is more steam left in the sector on the back of robust order books and improving earnings quality. They have recommended the preferred stocks to buy, hold or sell
Stay Bullish for target of 19100 in Nifty in December (26-11-2022)
Nifty Prediction for Dec: FIIS long to short ratio in the Index Futures is 3.28 which shows aggressive Long build up by FIIS in Index Futures. Put writing at 18000 levels is aggressive. Stock Futures’ Open Interest is lower. Stay Bullish for target of 19100